Source: Technolution Blog

Technolution Blog Bridging drug and device

Bridging drug and device Making the wrong choices when selecting auto-injector platform can potentially lead to a recall from the market resulting in a billion-dollar loss. Technolution's team of specialists have spent years helping clients bridge the gap between device and drug on end-to-end device development projects. With deep industry knowledge, we help clients identify [...]The post Bridging drug and device appeared first on Technolution.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Thomas Bach Agerslev's photo - CEO of Technolution

CEO

Thomas Bach Agerslev

CEO Approval Rating

90/100

Read more